More on Body Central (BODY): Q1 comes in-line with estimates. Overall revenue rose 11.8% Y/Y on a 13.6% rise in net store sales and a 10.1% increase in direct sales. The stock is being hammered in the post session however as the company lowers its Q2 forecast. It now expects an EPS of $0.26 - $0.28 per share and revenue to be in the range of $80M - $82M. Street estimates are for $87M in revenue and earnings of $0.36 per share. Shares -30.8% AH.